Ir a las Transacciones
TMT | Private Equity

GraphPad Software Inc. has completed a majority recapitalization with Insight Venture Partners

GraphPad Software Inc. (GraphPad), the premier provider of data analysis, statistics and graphing software solutions for scientific research applications, has completed a majority recapitalization with Insight Venture Partners, a leading global private equity and venture capital firm.

Headquartered in La Jolla, California, GraphPad offers powerful statistical analysis, curve fitting and graphing software solutions designed for scientists with varying levels of statistical knowledge. GraphPad’s flagship product, Prism, has become embedded in the regular workflow of researchers, such that experience with Prism is now an industry standard prerequisite for research positions across many disciplines of science.

Insight Venture Partners is an American venture capital and private equity firm based in New York City. The firm invests in growth-stage technology, software and Internet businesses. Founded in 1995, the firm has raised more than US$13 billion.

Osklins' team in Los Angeles advised the owners of GraphPad in this transaction.

Partes

Contáctese con el equipo de la transacción

Michael Rosenberg

Director Ejecutivo
Los Angeles, Estados Unidos
Oaklins Intrepid

Christopher H. Park

Director Ejecutivo
Los Angeles, Estados Unidos
Oaklins Intrepid

Ryan Makis

Director
Los Angeles, Estados Unidos
Oaklins Intrepid

Transacciones relacionadas

Den Berk Délice accelerates growth through strategic partnership
Private Equity | Agricultura

Den Berk Délice accelerates growth through strategic partnership

Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.

Conozca más
Xiel Limited has been acquired by MIS Healthcare
Private Equity | Salud

Xiel Limited has been acquired by MIS Healthcare

MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.

Conozca más
Microfinanciera Fundeser has been sold to Grupo Financiero Atlántida
Private Equity | Servicios Financieros

Microfinanciera Fundeser has been sold to Grupo Financiero Atlántida

Incofin has successfully exited its investment in Microfinanciera Fundeser in Nicaragua through two of its funds: Rural Impulse Fund II (RIF II) and agRIF. It has sold 100% of its stake in Microfinanciera Fundeser to Grupo Financiero Atlántida through its subsidiary, Inversiones Tres Lagos.

Conozca más